Phoenix Biotech Acquisition Corp. (PBAX) Stock Analysis

What Phoenix Biotech Acquisition Corp. does

Phoenix Biotech Acquisition Corp. currently lacks substantial business operations. The company's primary objective is to complete a strategic business combination, such as a merger, asset acquisition, share exchange, or other form of reorganization, with one or more suitable enterprises. Its focus is on identifying and integrating with a firm engaged in the healthcare or healthcare-related industries within the United States or Europe. This entity was established in 2021 and maintains its headquarters in Oakland, California.

Key metrics

ETFs linked to PBAX

Broad-market and Financial Services sector ETFs an investor holding Phoenix Biotech Acquisition Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how PBAX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Phoenix Biotech Acquisition Corp.?

Phoenix Biotech Acquisition Corp. trades under the ticker PBAX on NASDAQ.

Which exchange is PBAX listed on?

PBAX is listed on NASDAQ.

What sector does Phoenix Biotech Acquisition Corp. operate in?

Phoenix Biotech Acquisition Corp. is classified in the Financial Services sector (Shell Companies industry).

How can PortView help analyze PBAX in a portfolio?

PortView shows PBAX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.